This inventor holds 1 USPTO granted patent. Top assignees: Cns Biotek Corp., Gansu Evergreen Pharmaceuticals, Co., Ltd., Peking University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 667 
Years Active: 2025
Title: Chien-Ming Lee: Innovator in Pharmaceutical Composition Against SARS-CoV-2
Introduction
Chien-Ming Lee is a notable inventor based in Taitung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the fight against viral infections.
Latest Patents
One of his key patents is titled "Use of Ovatodiolide against SARS-CoV-2." This patent describes a compound of Formula I, known as Ovatodiolide, which is recognized for its safety and effectiveness in pharmaceutical compositions aimed at inhibiting SARS-CoV-2. The composition includes a safe and effective amount of Ovatodiolide or its pharmaceutically acceptable salts, combined with a suitable carrier. This innovation holds great potential for treating COVID-19, induced by SARS-CoV-2.
Career Highlights
Chien-Ming Lee has worked with prestigious institutions, including Peking University and Cns Biotek Corp. His work has focused on developing effective treatments for viral infections, showcasing his commitment to advancing medical science.
Collaborations
He has collaborated with notable colleagues such as Zhen Yang and Yew-Min Tzeng, contributing to the collective effort in pharmaceutical research and development.
Conclusion
Chien-Ming Lee's innovative work in developing Ovatodiolide as a treatment against SARS-CoV-2 highlights his significant role in the pharmaceutical industry. His contributions are vital in the ongoing battle against viral diseases, particularly COVID-19.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile